| Date | Title | Description | Source |
| 15.04.2024 | Women of Influence: Health Care 2024 – Ileana Hernandez | - | labusiness... |
| 08.03.2024 | CAR T-Cell Therapy Market Set for Healthy Growth after COVID... | CHICAGO, UNITED STATES, March 8, 2024 /EINPresswire.com/ -- Astute Analytica, a leading provider of ... | einpresswi... |
| 12.11.2020 | British biopharmaceutical company Grow Group PLC announces G... | | prnewswire... |
| 16.01.2020 | Clinical-Stage Biopharmaceutical Company Tarsus Pharmaceutic... | Clinical-stage biopharmaceutical company Tarsus Pharmaceuticals announced it raised $60 million in S... | pulse2.com... |
| 21.10.2019 | Olivia Zollinger becomes the first CEO of Swiss Healthcare S... | | startuptic... |
| 13.09.2019 | Anokion raises $40 million and acquires US biotech startup | | startuptic... |
| 26.08.2019 | Celgene to sell psoriasis drug to Amgen for $13.4B, clearing... | Shares of Celgene were up 3.7 percent in premarket trading on the Nasdaq Monday following the announ... | medcitynew... |
| 16.07.2019 | Celgene Exercises Commercial Option for Zymeworks’ Azymetric... | VANCOUVER, British Columbia–(BUSINESS WIRE) — Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biop... | lumiravent... |
| 17.05.2019 | Four years after EU approval, NICE finally backs Revlim... | Four years after the European Commission sanctioned the use of Celgene’s flagship Revlimid ... | endpts.com... |
| 22.04.2019 | Poseida raises $142M in Series C round to advance multiple m... | The company’s lead product candidate is P-BCMA-101, an autologous CAR-T that targets the BCMA antige... | medcitynew... |
| 18.04.2019 | Osage University Partners and Celgene Corp. Lead $75M Series... | WALTHAM, Mass.--(BUSINESS WIRE)--Arrakis Therapeutics, a biopharmaceutical company pioneering the di... | citybizlis... |
| 11.04.2019 | Asklepios BioPharmaceutical Receives $235M in Funding | Asklepios BioPharmaceutical, a developer and manufacturer of Adeno-Associated Virus (AAV) gene thera... | finsmes.co... |
| 08.04.2019 | Celgene, Acceleron submit FDA application for billed b... | Celgene and their partners at Acceleron are counting on their red blood cell boosting drug to w... | endpts.com... |
| 08.04.2019 | Celgene, Acceleron file for approval of blood disease drug l... | In a note to clients Sunday, Cowen analyst Yaron Werber wrote that the filing was in line with expec... | medcitynew... |
| 05.04.2019 | Bayer reports cyber attack pointed to Chinese hackers... | → Bayer has stopped a cyber attack in its tracks, the company said, seemingly without havin... | endpts.com... |
| 13.03.2019 | Celgene’s Abraxane flops in pivotal pancreatic cancer study... | Cannacord analysts John Newman and Christopher Liu wrote that because pancreatic cancer is a very di... | medcitynew... |
| 13.03.2019 | Celgene's chemotherapy Abraxane stumbles in pivotal pa... | Days after Celgene’s Abraxane secured approval in combination with Roche’s checkpoint inhi... | endpts.com... |
| 11.03.2019 | Is second time the charm for ozanimod? Celgene starts to... | Celgene has officially embarked on ozanimod’s comeback regulatory journey, submitting... | endpts.com... |
| 07.01.2019 |
NantCell Receives $30M More From Celgene, Now A $4 Billi... | Los Angeles-based NantCell, one of the biotech companies run by billionaire Dr. Patrick Soon-Shiong,... | socaltech.... |
| 06.01.2019 | Celgene adds $30 million to investment in Soon-Shiong firm N... | Drugmaker Celgene Corp. agreed to invest an additional $30 million in a cancer-fighting start-up tha... | sandiegoun... |
| 08.10.2018 | New biopharmaceutical company Sitryx launches with $30 milli... | - | svhealthin... |
| 23.09.2018 | Celgene Joins $47.5M Series A for Silverback Therapeutics | Silverback Therapeutics, Inc., a biotechnology company developing a pipeline of systemically deliver... | citybizlis... |
| 30.05.2018 | J&J to enter Chinese CAR-T for myeloma into Phase Ib/II ... | The CAR-T was originally developed by Nanjing, China-based Legend, under the development name LCAR-B... | medcitynew... |
| 25.05.2018 | FDA: Drugmaker ‘shenanigans’ delaying cheaper competitors an... | The FDA listed more than 50 drugs whose manufacturers have withheld or refused to sell samples, and ... | medcitynew... |
| 06.03.2018 | Gene therapy had banner year in 2017 with 164% funding boost... | The approvals include those for the CAR T-cell therapies Kymriah developed by Novartis that won FDA ... | medcitynew... |
| 01.02.2018 | Is too much money being invested in oncology? | Oncology is to funding as gravity is to everything else – but is it over the top? Is cancer investme... | medcitynew... |
| 22.01.2018 | Celgene Corporation to Acquire Juno Therapeutics | | biomarkcap... |
| 22.01.2018 | Anatomy of two biotech deals worth $20B | Celgene snags Juno Therapeutics for $9 billion
Background: Celgene is one of the hungriest biotechs ... | medcitynew... |
| 07.01.2018 | Developing a Sanofi cast-off, Impact Biomedicines now... | A startup developing the once-discarded fedratinib, a drug cast off from Sanofi due to safe... | endpts.com... |
| 04.01.2018 | Akiri to Create First Network-as-a-Service Platform Optimize... | San Fran-based Akiri launched with plans to bring the first network-as-a-service (NaaS) platform to ... | coverager.... |
| 21.12.2017 | Celgene, GV-backed FLX gets off $60M round, kick-starts I-O ... | FLX Bio has boosted its cash supplies with a new $60 million series C round as it starts dosing for ... | fiercebiot... |
| 26.10.2017 | In a pre-Halloween fright show, Celgene just scared the he... | For years now Celgene has impressed analysts and wowed investors with aggressive revenue gro... | endpts.com... |
| 06.07.2017 | Celgene joins the PD-1 checkpoint club, bagging BeiGene d... | Celgene is joining the fast growing PD-1 club.
John Oyler, BeiGene
The big biotech $CELG has tak... | endpts.com... |
| 27.02.2017 | Pfizer and Celgene Join $38M Series A For Arrakis Therapeuti... | WALTHAM, Mass.--(BUSINESS WIRE)--Arrakis Therapeutics, a pioneering biopharmaceutical company, has c... | citybizlis... |
| 15.02.2017 | Versant finishes Fund V with $20M NASH startup | As far as startups go, the bet looks relatively safe. Jecure’s executive team is proven and familiar... | medcitynew... |
| 26.01.2017 | Celgene scoops up freshman autoimmune startup Delinia i... | Four months ago, Atlas Venture partner Saurabh Saha set up shop at the newborn Delinia with a p... | endpts.com... |
| 26.01.2017 | Celgene acquires autoimmune startup Delinia for $775M | As recently as September 2016, Delinia was a fledgling autoimmune startup, launching with just four ... | medcitynew... |
| 30.11.2016 | Bluebird bio announces positive CAR-T results | Just over four months ago, the FDA put a temporary hold on the same Phase 2 ROCKET trial after two p... | medcitynew... |
| 01.11.2016 | Digital health deals: Virgin Pulse, Fitbit partner for emplo... | Fitbit has partnered with Virgin Pulse, a mobile-first employee wellness and engagement company, to ... | mobihealth... |
| 08.08.2016 | Little MEI Pharma rockets up on $25M cash injection, de... | Can a 4-cylinder biotech with an unconventional development partner help drive a largely ... | endpts.com... |
| 19.07.2016 | Celgene backs next-gen oncolytic virus startup in $57M Serie... | Newly unveiled Oncorus has raised a $57 million Series A to back its efforts to use next-gen oncolyt... | fiercebiot... |
| 05.04.2016 | Daily funding roundup - April 5, 2016 | Human Longevity bagged $220M Series B; Persado closed $30M; Sequoia Capital invested in Mintigo
Lond... | vator.tv/n... |
| 30.04.2015 | CRISPR Therapeutics Raises Additional $64 Million | | startuptic... |
| 21.01.2015 | Celgene, Biotech's Ace Dealmaker, Bets On Canada's Zymeworks | Celgene, the big maker of blood cancer drugs, has gained a reputation for anointing biotech startups... | forbes.com... |
| 31.01.2014 | East Coast Biotech Roundup: Dicerna, J&J, Neurophage, &a... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
[Updated, 8:44 am ET] Local biotech... | xconomy.co... |
| 07.10.2013 | PharmAkea Therapeutics Raises Series A Financing | PharmAkea Therapeutics, Inc., a San Diego, CA-based developer of a drug discovery platform to genera... | finsmes.co... |
| 31.08.2012 | Former court foes Penn and pharma company forge cancer thera... | “Agios Pharmaceuticals and The University of Pennsylvania (“Penn”) today announced that, in connecti... | medcitynew... |
| 23.07.2012 | Late-stage cystic fibrosis, muscular dystrophy drug raises $... | With cystic fibrosis the goal is to improve lung function and reduce pulmonary exacerbation. In a Ph... | medcitynew... |
| 21.06.2012 | Celgene’s multiple myeloma drug setback in Europe gets mixed... | Sanford Bernstein analyst Geoffrey Porges criticized the company’s management in a Forbes article fo... | medcitynew... |
| 26.04.2012 | Celgene submits NDA for multiple myeloma, forges personalize... | Celgene also has a phase 3 trial under way that is using the Abraxane in the treatment of metastatic... | medcitynew... |
| 09.04.2012 | Celgene in strategic discovery deal with therapeutic antibod... | Celgene (NASDAQ:CELG) has agreed to a strategic discovery deal with a company that is developing ant... | medcitynew... |
| 10.02.2012 | Startupalooza highlights digital health companies: Epion Hea... | Startupalooza NJ is a competition in which technology, digital health and medical device companies c... | medcitynew... |
| 09.02.2012 | Acetylon Pharmaceuticals Raises $15M |
BOSTON, MA, Acetylon Pharmaceuticals announced that Celgene Corporation (NASDAQ: CELG) will invest... | vcnewsdail... |
| 09.02.2012 | Celgene invests $15 million for closer collaboration with ca... | Walter C. Ogier, Acetylon’s president and chief executive officer, said in a company statement:
“The... | medcitynew... |
| 09.02.2012 | Acetylon Pharmaceuticals Receives $15M Investment from Celge... | Acetylon Pharmaceuticals, a Boston, MA-based developer of small molecule drugs to realize the therap... | finsmes.co... |
| 03.02.2012 | At Bio NJ, Gov. Chris Christie takes on Snooki, losing chief... | A report published last month by the HealthCare Institute of New Jersey said the pharmaceutical and ... | medcitynew... |
| 26.01.2012 | Celgene cancer drug acquisition may bode well for life scien... | Celgene (NYSE:CELG) has acquired cancer drug developer Avila Therapeutics in a deal valued up to $92... | medcitynew... |
| 23.12.2011 | Acceleron Pharma Raises $30M in Funding | Acceleron Pharma, Inc., a Cambridge, MA-based biopharmaceutical company developing protein therapeut... | finsmes.co... |
| 17.11.2011 | Agios Pharmaceuticals Raises $78M in Series C Financing | Agios Pharmaceuticals, a Cambridge, Massachusetts-based biopharmaceutical company focused on discove... | finsmes.co... |
| 28.10.2011 | Earnings roundup: Bristol-Myers Squibb and Celgene | Among the drugs in the pipeline are a new blood clot preventer called Eliquis developed with Pfizer ... | medcitynew... |
| 12.01.2010 |
VentiRx Gets $25M In Series A Extension
| San Diego-based biopharmaceuticals firm VentiRx Pharmaceuticals said today that the firm has raised ... | socaltech.... |
| 12.01.2010 | VentiRx Pharmaceuticals Raises $25M in Series A Extension Fi... | VentiRx Pharmaceuticals, Inc., a San Diego, CA-based biopharmaceutical company focused on the develo... | finsmes.co... |
| 07.10.2009 | Schering-Plough launches schizophrenia, bi-polar disorder dr... | Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems stri... | medcitynew... |
| 26.08.2009 | USA, Gloucester Pharmaceuticals closed a $29m series D finan... | Gloucester Pharmaceuticals raised $29m in a Series D financing led by new investor Novo Ventures and... | finsmes.co... |
| 05.11.2008 | Ferrokin brings in $8.4M for anemia treatment | Ferrokin Biosciences, a San Carlos Calif. company that makes compounds to treat iron overload in pat... | venturebea... |
| 06.03.2007 |
VentiRx Raises $28.9M
| San Diego-based VentiRx Pharmaceuticals announced today that it has raised $28.9M in funding for the... | socaltech.... |
| - | Celgene to sell psoriasis drug to Amgen for $13.4B, clearing... | Drugmaker Bristol-Myers Squibb and biotech company Celgene have found a buyer for a Celgene drug tha... | medcitynew... |
| - | Schering-Plough launches schizophrenia, bi-polar disorder dr... | CLEVELAND, Ohio – Sometimes acquiring other drugmakers is the way to fill your company’s develop... | medcitynew... |
| - | Celgene cancer drug acquisition may bode well for life scien... | Celgene (NYSE:CELG) has acquired cancer drug developer Avila Therapeutics in a deal valued up to $92... | medcitynew... |
| - | At Bio NJ, Gov. Chris Christie takes on Snooki, losing chief... | New Jersey Gov. Chris Christie held forth at the New Jersey biotechnology association NJ Bio annual ... | medcitynew... |
| - | Celgene submits NDA for multiple myeloma, forges personalize... | Celgene (NASDAQ:CELG) has submitted a new drug application to the U.S. Food and Drug Administration ... | medcitynew... |
| - | Poseida raises $142M in Series C round to advance multiple m... | A Swiss drugmaker that markets one of the two approved CAR-T cell therapies has led the latest finan... | medcitynew... |
| - | Startupalooza highlights digital health companies: Epion Hea... | Startupalooza NJ is a competition in which technology, digital health and medical device companies c... | medcitynew... |
| - | J&J to enter Chinese CAR-T for myeloma into Phase Ib/II ... | A Chinese CAR-T therapy that drew significant attention at last year’s American Society of Clinical ... | medcitynew... |
| - | Celgene’s Abraxane flops in pivotal pancreatic cancer study... | Shortly after the Food and Drug Administration approved a combination using it with the first-ever i... | medcitynew... |
| - | Celgene in strategic discovery deal with therapeutic antibod... | Celgene (NASDAQ:CELG) has agreed to a strategic discovery deal with a company that is developing ant... | medcitynew... |
| - | Former court foes Penn and pharma company forge cancer thera... | An unusual lawsuit between the University of Pennsylvania, the university’s Abramson Cancer Center a... | medcitynew... |
| - | Celgene acquires autoimmune startup Delinia for $775M | On Thursday, Summit, New Jersey-based Celgene Corporation announced plans to acquire Delinia for an ... | medcitynew... |
| - | Celgene, Acceleron file for approval of blood disease drug l... | Two drugmakers have submitted an approval application to the Food and Drug Administration for a drug... | medcitynew... |
| - | Earnings roundup: Bristol-Myers Squibb and Celgene | Bristol-Myers Squibb (NYSE:BMS) posted net income of $969 million in the third quarter of 2011 and i... | medcitynew... |
| - | Late-stage cystic fibrosis, muscular dystrophy drug raises $... | A biopharmaceutical company with a cystic fibrosis drug in late-stage development has raised $30 mil... | medcitynew... |
| - | Is too much money being invested in oncology? | Between venture capitalists flush with cash and corporate mergers and acquisitions, money is gushing... | medcitynew... |
| - | Celgene’s multiple myeloma drug setback in Europe gets mixed... | Celgene’s (NASDAQ:CELG) move to withdraw its multiple myeloma drug Revlimid new application submissi... | medcitynew... |
| - | See the 24-slide pitch deck a new biotech startup just used ... | Jak Knowles, CEO and cofounder of Affini-T Therapeutics Affini-T Therapeutics This story is availabl... | businessin... |
| - | Celgene invests $15 million for closer collaboration with ca... | Celgene (NYSE:CELG) has made a $15 million strategic investment in a cancer drug developer, which gi... | medcitynew... |
| - | Gene therapy had banner year in 2017 with 164% funding boost... | Calling 2017 a “banner year for regenerative and advanced therapies,” the Alliance for Regenerative ... | medcitynew... |
| - | Versant finishes Fund V with $20M NASH startup | San Diego, California-based Jecure officially debuted on Wednesday, bringing a new platform and rese... | medcitynew... |
| - | FDA: Drugmaker ‘shenanigans’ delaying cheaper competitors an... | Makers of brand-name drugs called out by the Trump administration for potentially stalling generic c... | medcitynew... |
| - | Bluebird bio announces positive CAR-T results | The CAR-T field can rest a little easier, reassured by Wednesday’s positive interim results from blu... | medcitynew... |
| - | Anatomy of two biotech deals worth $20B | Analysts had forecast a blockbuster year for life science mergers and acquisitions as the lower tax ... | medcitynew... |
